ReviewSensors (Basel, Switzerland)2025
A Review of Graphene-Integrated Biosensors for Non-Invasive Biochemical Monitoring in Health Applications.
Review in Sensors (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Next generation smart functionalized nanocomposites for ultrasensitive and real time detection of purine derived metabolic biomarkers.RSC advances · 2026Review
- Digital and Biomarker-Based Monitoring for Schizophrenia-Treatment Adherence.Neuropsychopharmacology reports · 2026Review
- Smart wearable biosensors: a transformative synergy between diagnosis and treatment of disease.RSC advances · 2026Review
- Recent advances in hybrid nano-interfaces for environmental pollutant detection: design principles, signal transduction, and analytical performance.Mikrochimica acta · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
This review explores the transformative potential of graphene-based, non-invasive biochemical sensors in the context of real-time health monitoring and personalised medicine. Traditional diagnostic methods often involve invasive procedures that can be uncomfortable, pose risks, and limit the frequency of monitoring. In contrast, wearable sensors incorporating graphene offer a compelling alternative by enabling continuous, real-time tracking of physiological and biochemical signals with minimal intrusion. Graphene's exceptional electrical conductivity, mechanical flexibility, biocompatibility, and high surface-area-to-volume ratio make it ideally suited for integration into skin-conformal sensor platforms. These properties not only enhance sensitivity and signal fidelity but also promote user comfort and long-term wearability, critical factors for the adoption of wearable health technologies. The discussion evaluates current developments in the design and deployment of graphene-based biosensors, with particular attention given to their role in managing chronic conditions, supporting preventative healthcare, and facilitating decentralised diagnostics. By bridging materials science and biomedical engineering, this review positions graphene as a key enabler in the shift towards more proactive, patient-centred healthcare models. The text also identifies ongoing challenges and future directions in sensor design, aiming to inform researchers working at the intersection of advanced materials and medical technology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.